Impact of COVID-19 on Nonpulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes

Overview

Journal Clin Chest Med

Specialty Pulmonary Medicine

Date 2023 Apr 21

PMID 37085218

Authors

Mina Pirzadeh

Hallie C Prescott

Affiliations

Soon will be listed here.

Abstract

Although respiratory manifestations are the most common driver of hospitalization, SARS-CoV-2 infection has a wide range of manifestations, including multisystem organ failure in severe cases. This review discusses the prevalence, pathophysiology, clinical manifestations, treatment, and outcomes of nonpulmonary organ dysfunction from SARS-CoV2, including renal, liver, cardiac, neurologic, and coagulation system dysfunction. At this time, management largely focuses on supportive care practices that are applicable regardless of the cause of organ injury.

References

Ding Z, Li G, Chen L, Shu C, Song J, Wang W . Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2020; 74(6):1295-1302. PMC: 7749734. DOI: 10.1016/j.jhep.2020.12.012. View

. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021; 397(10285):1637-1645. PMC: 8084355. DOI: 10.1016/S0140-6736(21)00676-0. View

Bocci T, Campiglio L, Zardoni M, Botta S, Coppola S, Groppo E . Critical illness neuropathy in severe COVID-19: a case series. Neurol Sci. 2021; 42(12):4893-4898. PMC: 8414960. DOI: 10.1007/s10072-021-05471-0. View

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S . AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2020; 32(1):151-160. PMC: 7894657. DOI: 10.1681/ASN.2020050615. View

Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K . SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020; 51(7):2002-2011. PMC: 7258764. DOI: 10.1161/STROKEAHA.120.030335. View

Wichmann D, Sperhake J, Lutgehetmann M, Steurer S, Edler C, Heinemann A . Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; 173(4):268-277. PMC: 7240772. DOI: 10.7326/M20-2003. View

Zhao B, Liu W, Lei S, Zhou B, Yang X, Huang T . Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis. J Intensive Care. 2020; 8(1):88. PMC: 7682759. DOI: 10.1186/s40560-020-00508-6. View

Gorog D, Storey R, Gurbel P, Tantry U, Berger J, Chan M . Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol. 2022; 19(7):475-495. PMC: 8757397. DOI: 10.1038/s41569-021-00665-7. View

Jackson J, Pandharipande P, Girard T, Brummel N, Thompson J, Hughes C . Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014; 2(5):369-79. PMC: 4107313. DOI: 10.1016/S2213-2600(14)70051-7. View

10.

White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D . Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020; 50(2):287-291. PMC: 7242778. DOI: 10.1007/s11239-020-02145-0. View

11.

Shappell C, Klompas M, Rhee C . Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond. Crit Care Med. 2021; 49(12):2140-2143. PMC: 8594516. DOI: 10.1097/CCM.0000000000005207. View

12.

Farshidfar F, Koleini N, Ardehali H . Cardiovascular complications of COVID-19. JCI Insight. 2021; 6(13). PMC: 8410051. DOI: 10.1172/jci.insight.148980. View

13.

Merkler A, Parikh N, Mir S, Gupta A, Kamel H, Lin E . Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020; . PMC: 7333175. DOI: 10.1001/jamaneurol.2020.2730. View

14.

Kramer A, Prinz C, Fichtner F, Fischer A, Thieme V, Grundeis F . Janus kinase inhibitors for the treatment of COVID-19. Cochrane Database Syst Rev. 2022; 6:CD015209. PMC: 9190191. DOI: 10.1002/14651858.CD015209. View

15.

Ng J, Hirsch J, Hazzan A, Wanchoo R, Shah H, Malieckal D . Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis. 2020; 77(2):204-215.e1. PMC: 7833189. DOI: 10.1053/j.ajkd.2020.09.002. View

16.

Sharma P, Uppal N, Wanchoo R, Shah H, Yang Y, Parikh R . COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol. 2020; 31(9):1948-1958. PMC: 7461689. DOI: 10.1681/ASN.2020050699. View

17.

Morassi M, Bagatto D, Cobelli M, Dagostini S, Gigli G, Bna C . Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020; 267(8):2185-2192. PMC: 7238403. DOI: 10.1007/s00415-020-09885-2. View

18.

Lala A, Johnson K, Januzzi J, Russak A, Paranjpe I, Richter F . Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020; 76(5):533-546. PMC: 7279721. DOI: 10.1016/j.jacc.2020.06.007. View

19.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

20.

Braun F, Lutgehetmann M, Pfefferle S, Wong M, Carsten A, Lindenmeyer M . SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. 2020; 396(10251):597-598. PMC: 7431179. DOI: 10.1016/S0140-6736(20)31759-1. View